tti-622
Showing 1 - 4 of 4
Lymphoma, Multiple Myeloma Trial in Nagoya, Koto, Yamagata (TTI-622)
Recruiting
- Lymphoma
- Multiple Myeloma
- TTI-622
-
Nagoya, Aichi, Japan
- +2 more
Jan 20, 2023
Multiple Myeloma Trial in United States (TTI-622, Daratumumab Hyaluronidase-fihj)
Recruiting
- Multiple Myeloma
- TTI-622
- Daratumumab Hyaluronidase-fihj
-
Basking Ridge, New Jersey
- +6 more
Dec 8, 2022
Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in Santa Monica, Pittsburgh, Houston (TTI-622, Pegylated Liposomal
Recruiting
- Ovarian Cancer
- +5 more
- TTI-622
- Pegylated Liposomal Doxorubicin
-
Santa Monica, California
- +4 more
Jul 26, 2022
Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)
Recruiting
- Lymphoma
- +3 more
- TTI-622
- +6 more
-
Los Angeles, California
- +36 more
Jan 23, 2023